Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoThat RS Rating means Pfizer stock ranks in the bottom 28% of all stocks in terms of performance over...
Council Post: Embracing Advanced Tech In The Food And Beverage Industry, Part 3: Becoming...
Forbes· 4 days agoGary Iles is the senior vice president of marketing and business development at TraceGains. For food...
FDA confirms robotic prostatectomy survival rates match traditional surgery By Investing.com
Investing.com· 3 days agoThe U.S. Food and Drug Administration (FDA) has approved a labeling revision for Intuitive's da...
Edwards Life Sciences sees positive results from TAVR trial
Medical Device Network via Yahoo Finance· 2 days ago“These data are reassuring for patients and clinicians – particularly women who are more likely to...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 6 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Zombies: Ranks of world's most debt-hobbled companies are soaring - and not all will survive
Newsday· 1 day agoThey are called zombies, companies so laden with debt that they are just stumbling by on the brink of survival, barely able to pay even the interest on their loans and often ...
Last remaining Second World War escort ship risks being scrapped
Daily Telegraph· 5 days agoThe last remaining Second World War escort ship risks being scrapped unless £150,000 can be raised...
Boeing's first astronaut flight called off at the last minute in latest setback
Tulsa World· 7 days agoA last-minute problem nixed Saturday's launch attempt for Boeing's first astronaut flight, the...
Ducks Unlimited Builds On History Of Success To Launch $3 Billion Campaign
Forbes· 3 days agoThe extended drought across the Great Plains and elsewhere highlighted the importance of conserving...
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the...
Benzinga· 2 days agoApproval across ESA ineligible and ESA relapsed/refractory patients with LR-MDS with transfusion-dependent anemia, regardless of ring sideroblast (RS) status Durable and sustained red blood cell transfusion